Albireo Pharma (NASDAQ:ALBO) Earnings Information
Albireo Pharma last issued its quarterly earnings results on February 24th, 2021. The biopharmaceutical company reported ($1.30) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.90) by $0.60. Albireo Pharma has generated ($5.04) earnings per share over the last year. Albireo Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 6th, 2021 based off prior year's report dates.
Albireo Pharma Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Albireo Pharma (NASDAQ:ALBO) Earnings Estimates
2021 EPS Consensus Estimate: ($6.47)
2022 EPS Consensus Estimate: ($5.53)
Albireo Pharma (NASDAQ ALBO) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)